HomeClinical TopicsFDA warns of risk of death from postop codeine use in children

FDA warns of risk of death from postop codeine use in children

Author(s):

On Aug. 15, the U.S. Food and Drug Administration (FDA) issued a warning about risk of death from postop codeine use in children following tonsillectomy and/or adenoidectomy. The warning resulted from reports of three deaths and one life-threatening case of respiratory depression. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content

For Nurse Practitioners

Couple talking to NP

Getting Covid Vaccine Won’t Hurt Pregnancy Chances; Getting Covid Could

Couples planning a pregnancy might be relieved to know that getting a Covid vaccine does not hurt their odds of conceiving, according to the...